Browsing: Hypoparathyroidism

PICO

Does TransCon PTH (palopegteriparatide) improve outcomes in Adults with hypoparathyroidism?

By FWAMarch 18, 20250

Brief Results In Adults with hypoparathyroidism, TransCon PTH (palopegteriparatide) administered once daily compared to Placebo showed At week 52, 81%…

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

CONTACT INFO

Privacy Policy
Disclaimer

Browsing: Hypoparathyroidism

Does TransCon PTH (palopegteriparatide) improve outcomes in Adults with hypoparathyroidism?

Once-Weekly Semaglutide Shows Promise in Improving Glycaemic Control and Weight Loss for Type 2 Diabetes Patients, Study Finds

Study Finds Semaglutide Reduces Cardiovascular Risk in Type 2 Diabetes Patients, but Raises Retinopathy Concerns

Study Shows Once-Weekly Semaglutide Effectively Lowers Blood Sugar and Aids Weight Loss in Type 2 Diabetes Patients

Once-Weekly Semaglutide Outperforms Daily Sitagliptin in Blood Sugar and Weight Control for Type 2 Diabetes Patients

Subscribe now

CATEGORIES

CONTACT INFO